Search

everythinglearnresearchcommunity

for

Search:↓

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Suppressing certain hormones might help prevent prostate cancer.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Spironolactone successfully treated hair loss in a 9-year-old girl.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Latanoprost may cause scalp inflammation and delayed healing.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Spironolactone may help reduce hair loss in androgenic alopecia.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.